Novel Androgen Deprivation Treatment for Advanced Prostate Cancer: Optimizing Benefits, Mitigating Risk

Access Activity

Overview / Abstract:

Target Audience
This activity is designed to meet the educational needs of medical oncologists, nurse practitioners, and other healthcare professionals who care for patients with prostate cancer.

Program Overview
Join Drs. Robert Dreicer and Michael Cookson as they review the principles of androgen deprivation therapy and discuss the latest clinical data for recently approved ADT agents and studies of ADT-based combination regimens in the treatment of men with metastatic hormone sensitive prostate cancer (mHSPC). The evolving guideline-directed evidence-based approaches for therapeutic intensification in the treatment of mHSPC are also discussed. Listen to the faculty discuss case studies to gain practical insights into choosing optimal therapies that incorporate ADT for individual patients and balance patient preferences with therapeutic goals.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Explain the differences between luteinizing hormone-releasing hormone agonists and gonadotropin-releasing hormone antagonists in terms of mechanism of action and outcomes
Select optimal therapy to avoid/reduce cardiovascular risk in patients with advanced prostate cancer
Compare and contrast the latest evidence regarding options for patients with advanced prostate cancer
Develop treatment strategies incorporating patient-specific factors, including risk factors, concerns, preferences, and adherence information regarding oral vs injectable oncologic therapy


Dec 21, 2022


Physician CME



Credits / Hours




Presenters / Authors / Faculty

Robert Dreicer, MD, MS, MACP
Michael S. Cookson, MD, MMHC

Sponsors / Supporters / Grant Providers

Pfizer Inc. and Myovant Sciences Ltd

Keywords / Search Terms

Relias LLC Relias, Free CME, Prostate cancer Free CE CME

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map